表紙
市場調查報告書
商品編碼
977644

生物銀行市場 - 預測,主要企業,COVID-19復甦情境:2021年∼2031年

Biobanking Market Report 2021-2031: Forecasts by Biobank Type (Standalone, Partnership), Application, Sample Type (Bio-fluids, Human Tissue/Tumor Cells, Stem Cells, DNA/RNA), Ownership, Region, Leading Companies, COVID-19 Recovery Scenarios

出版日期: | 出版商: Visiongain Ltd | 英文 360 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

臨床實驗上,在跟COVID-19的戰鬥中,生物銀行發揮重要作用。

本報告提供全球生物銀行市場相關調查分析,市場概要,市場分析與預測,各地區的市場預測,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 生物銀行和應用的簡介

第3章 摘要整理

第4章 產業考察

  • 促進因素
  • 阻礙因素
  • 機會
  • 趨勢
  • 生物銀行市場優點與缺點
  • 生物銀行市場機會和威脅
  • 產業分析:波特的五力分析
  • 產業分析:PEST分析

第5章 生物銀行的清單:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 研究目的商業生物銀行
  • 治療目的有力生物銀行

第6章 生物銀行技術:生物銀行相關的系統軟體、消耗品、服務

  • 生物銀行相關市場:概要
  • 系統技術:全自動處理
  • 保管技術:永續性,容易的樣品追蹤,安全的追加
  • 生物銀行軟體
  • 對消耗品:有效的樣品管理必要的高品質
  • 生物銀行服務:生物學的樣品的保管、管理、運輸

第7章 生物銀行市場:生物銀行各類型(包含COVID-19前、復甦情境)

  • 獨立的
  • 夥伴關係

第8章 生物銀行市場:各用途(包含COVID-19前、復甦情境)

  • 研究用途
  • 治療用途

第9章 包含生物銀行市場:各樣品類型(包含COVID-19前、復甦情境)

  • 體液
  • 人組織/癌細胞
  • 幹細胞
  • DNA/RNA
  • 其他樣品類型

第10章 生物銀行市場:擁有(包含COVID-19前、復甦情境)

  • 國家/地區
  • 大學
  • 非營利團體
  • 民間

第11章 各地區、主要國家的生物銀行市場預測

  • 全球生物銀行市場預測:各地區
  • 復甦情境(V,U,W,L)

第12章 北美的生物銀行市場預測

第13章 歐洲的生物銀行市場預測

第14章 亞太地區的生物銀行市場預測

第15章 南美、中東、非洲的生物銀行市場預測

第16章 企業簡介

  • Thermo Fisher Scientific Inc.
  • Merck & Co.
  • QIAGEN
  • Danaher
  • STEMCELL Technologies Inc.
  • BioLifeSolutions Inc.
  • BioCision
  • VWR International, LLC.
  • Hamilton Company
  • Becton, Dickinson and Company (BD)

第17章 結論

目錄
Product Code: PHA0932

Title:
Biobanking Market Report 2021-2031
Forecasts by Biobank Type (Standalone, Partnership), Application (Research, Therapeutics), Sample Type (Bio-fluids, Human Tissue/Tumor Cells, Stem Cells, DNA/RNA, Other Sample Types), Ownership (National/ Regional, Universities, Non-Profit, Private), Region (North America, Europe, Asia Pacific, LAMEA). PLUS Analysis of Leading Biobanking Companies AND COVID-19 Recovery Scenarios.

Within clinical trials and therefore in the fight against COVID-19, biobanks will play an essential role. How can you and your organization be part of this?

The race for a COVID-19 solution is not just a race for profit or market share, but a race to save increased death, and rescue the global economy. Your company needs to be involved today.

What are the Market Opportunities & Threats? This report tells you NOW

  • High Potential of Stem Cell Therapeutics in Unmet Clinical Needs
  • Importance of Networking & Exchange Between Biobanks
  • Growing Demand for Biobanked Samples for Preclinical Research
  • Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
  • Even with Government Funding, Biobanks Must Become Self Sufficient to Thrive Long-Term
  • Public Concerns Over Confidentiality and Security Threaten Availability of Donors

UNIQUE COVID-19 VARIATIONS only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 affects the economy.

Which Factors are Fueling Biobanking Industry Growth?

  • Rising R&D Expenditure
  • Growing Chronic Disease Burden
  • Biobanks Are Critical for Cancer Research
  • Government Funding to Fuel Market Growth

Which Factors are Restraining Growth?

  • Legal & Ethical Challenges in Biobanking
  • Lack of Standardization of Approval Required
  • Issues in Developing Biobanks & Using Stored Specimens

How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. This report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks. You must read this.

Discover how to stay ahead

Our 360-page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking Market. See how to exploit opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter's Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Biobank Type

  • Standalone
  • Partnership

Application

  • Research
  • Therapeutics

Sample Type

  • Bio-fluids
  • Human Tissue/Tumor Cells
  • Stem Cells
  • DNA/RNA
  • Other Sample Types

Ownership

  • National/ Regional
  • Universities
  • Non-Profit
  • Private

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 13 leading national markets:

By Region

  • North America:
    • U.S.
    • Canada
  • Europe:
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Denmark
    • Finland
    • Rest of Europe
  • Asia Pacific:
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • LAMEA

Leading companies and the potential for market growth

Overall world revenue for Biobanking Market will surpass $xx billion in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market- including company profiles for 10 of the major companies involved in the Biobanking Market. Some of the companies profiled in this report include Thermo Fisher Scientific Inc., Merck & Co., QIAGEN, Danaher, STEMCELL Technologies Inc., BioLifeSolutions Inc., BioCision, VWR International, LLC., Hamilton Company, and Becton, Dickinson, and Company (BD).

Key Questions Answered by this Report:

  • What is the current size of the overall global Biobanking market? How much will this market be worth from 2021 to 2031?
  • What are the main drivers and restraints that will shape the overall biobanking market over the next ten years?
  • What are the main segments within the overall Biobanking market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
  • What factors will affect that industry and market over the next ten years?
  • What are the largest national markets for the world Biobanking? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
  • How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
  • Which are the leading companies and what are their activities, results, developments, and prospects?
  • What are the main trends that will affect the world Biobanking market between 2021 and 2031?
  • What are the main strengths, weaknesses, opportunities, and threats for the market?
  • How will the global Biobanking market evolve over the forecasted period, 2021 to 2031?
  • How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is intended for everybody needing commercial analyses for the Global Biobanking Market and leading companies. You will find data, trends and predictions.

Get our report today Biobanking Market Report 2021-2031: Forecasts by Biobank Type (Standalone, Partnership), Application (Research, Therapeutics), Sample Type (Bio-fluids, Human Tissue/Tumor Cells, Stem Cells, DNA/RNA, Other Sample Types), Ownership (National/ Regional, Universities, Non-Profit, Private), Region (North America, Europe, Asia Pacific, LAMEA). PLUS Analysis of Leading Biobanking Companies AND COVID-19 Recovery Scenarios.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Biobanking Market
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered by This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 COVID-19 Impact: Recovery Scenarios
    • 1.6.2 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Introduction to Biobanking and its Applications

  • 2.1 Defining the Human Tissue Banking Market for the Scope of this Report
  • 2.2 The Stem Cell Banking Market - Our Breakdown
  • 2.3 What is Biobanking?
  • 2.4 Main Features of Biobanks
  • 2.5 What Processes are Involved in Biobanking?
  • 2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
    • 2.6.1 Volunteer Group: General vs. Disease Population
    • 2.6.2 Ownership Structure: Public vs. Private
  • 2.7 Harmonization of Bio Banking and Initiatives Taken by Various Organizations
  • 2.8 Biobank Funding and Financial Sustainability
  • 2.9 The Guidelines and Standards for Biobanking
  • 2.10 Laws and Regulations for Biobank-Based Research
    • 2.10.1 HIPAA Amendments
  • 2.11 Biobanking and the Pharmaceutical Industry
    • 2.11.1 Biobanking in Research, Drug Discovery and Development
    • 2.11.2 Biobanking for Therapeutic Purposes
    • 2.11.3 Biobanking in Clinical Trials

3 Executive Summary

4 Industry Insights

  • 4.1 Drivers
    • 4.1.1 Rising R&D Expenditure
    • 4.1.2 Rising Chronic Disease Burden
    • 4.1.3 Biobanks Are Critical for Cancer Research
    • 4.1.4 Government Funding to Fuel Biobanking Market Growth
  • 4.2 Restraints
    • 4.2.1 Legal and Ethical Challenges in Biobanking
    • 4.2.2 Lack of Standardization of Approvals Required
    • 4.2.3 Issues in Developing Biobanks and Using Stored Specimens
  • 4.3 Opportunities
    • 4.3.1 High Potential of Stem Cell Therapeutics in Unmet Clinical Needs
    • 4.3.2 Importance of Networking and Exchanges Between Biobanks
  • 4.4 Trends
    • 4.4.1 The Growing Demand for Biobank Resources for Research
    • 4.4.2 The Establishment of Biobanking Networks
    • 4.4.3 Virtual Biobanks: Connecting a Fragmented Industry
    • 4.4.4 Commercial Biobanks as Intermediaries: New Resources for Research
    • 4.4.5 Automated Biobanking Has Become Imperative
    • 4.4.6 Increasing Uptake of LIMS
    • 4.4.7 Green Banking - Becoming More Energy Efficient
  • 4.5 Strengths & Weakness of Biobanking Market
    • 4.5.1 HBS Are Valuable Resources for R&D
    • 4.5.2 Government Funding to Fuel Market Growth
    • 4.5.3 Development of Potential Novel Stem Cell Therapies Has Increased Public Awareness of Stem Cell Banking
    • 4.5.4 Emergence of Big Data in Biobanking
    • 4.5.5 Insufficient Accessible Numbers of High Quality Biospecimens
    • 4.5.6 Biobanks Are Fragmented and Uncoordinated
    • 4.5.7 Lack of Standardization is a Weakness
    • 4.5.8 Lack of Public Awareness Limits Number of Donors
    • 4.5.9 Lack of Engagement with Public Health Services Limits The Stem Cell Banking Market
  • 4.6 Opportunities & Threats of Biobanking Market
    • 4.6.1 Increasing Use of Biobanked Specimens in Genome Wide Association Studies (GWAS)
    • 4.6.2 Growing Demand for Biobanked Samples for Preclinical Research
    • 4.6.3 Biobanks as A Basis for Personalized Medicine
    • 4.6.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
    • 4.6.5 Even with Government Funding, Biobanks Must Become Self Sufficient to Thrive Long-Term
    • 4.6.6 Public Concerns Over Confidentiality and Security Threaten Availability of Donors
  • 4.7 Industry analysis - Porter's
    • 4.7.1 Low Buyer Power
    • 4.7.2 Low Supplier Power
    • 4.7.3 High-Competitive Rivalry
    • 4.7.4 Low Threat of Substitute
    • 4.7.5 Moderate Threat of New Entrants
  • 4.8 Industry analysis - PEST Analysis
    • 4.8.1 Political
    • 4.8.2 Economical
    • 4.8.3 Social
    • 4.8.4 Technological

5 List of Biobanks by Geographical Region

  • 5.1 North America
  • 5.2 Europe
  • 5.3 Asia Pacific
  • 5.4 MEA
  • 5.5 Commercial Biobanks for Research Purposes
    • 5.5.1 Tissue Solutions: A Virtual Biobank with a Global Presence
    • 5.5.2 An Overview of the Products and Services Offered by Tissue Solutions
    • 5.5.3 Banked Samples Occur in Many Formats
    • 5.5.4 Prospective Tissue Collection for Hard-to-Find Samples
    • 5.5.5 Fresh Samples from Surgical Resections are in High Demand
    • 5.5.6 Freshly Isolated Human Cells are a Valuable Research Tool
    • 5.5.7 FDA/EMA Panel of Normal Tissues
    • 5.5.8 Strengths, Capabilities and the Future Outlook for Tissue Solutions
    • 5.5.9 Asterand Bioscience is now Part of Stemgent
    • 5.5.10 Biopta: Human Tissue Provider Now Acquired by Japanese Company ReproCELL
    • 5.5.11 BioServe: One of the World's Largest Commercial Biorepositories
    • 5.5.12 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
  • 5.6 Prominent Biobanks for Therapeutic Use
    • 5.6.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled, Strategic Alternatives Being Considered
    • 5.6.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
    • 5.6.3 Cryo-Save's Educational Programme Benefits Company's Growth
    • 5.6.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences Is Under a New Owner
    • 5.6.5 LifebankUSA: Acquisition from Human Longevity Inc Will Potentially Drive Growth
    • 5.6.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
    • 5.6.7 Cord Blood Registry: The World's Largest Newborn Stem Cell Company Will Be Promoted by New Parent Company
    • 5.6.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
    • 5.6.9 StemLife is Reportedly Facing Challenges due to Government Regulations in Malaysia
    • 5.6.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
    • 5.6.11 Caladrius Biosciences (formerly NeoStem): More Focus on Cell Therapy Than Stem Cell Banking
    • 5.6.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India

6 Technology for Biobanking: Systems, Software, Consumables, and Services Associated with Biobanking

  • 6.1 The Biobanking-Associated Market: Overview
  • 6.2 Systems Technology: Fully Automated Handling
    • 6.2.1 Automated Liquid Handling Systems
    • 6.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
    • 6.2.3 Automated DNA Isolation
  • 6.3 Storage Technology: Sustainability, Easy Sample Tracking, and Added Security
    • 6.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
    • 6.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
    • 6.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
    • 6.3.4 Automated Storage and Retrieval Systems: Essential Technology
    • 6.3.5 RFID and Tagging Technology: Advantages over Barcodes
  • 6.4 Software for Biobanks
    • 6.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
    • 6.4.2 LIMS Functions
  • 6.5 Consumables: High Quality Required for Effective Sample Management
    • 6.5.1 Addressing Sample Storage and Tracking Issues
  • 6.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee

7 Biobanking Market by Biobank Type (Pre COVID & Recovery Scenarios Included)

  • 7.1 Standalone Sub-Segment Market Forecast, 2021-2031
    • 7.1.1 Introduction
    • 7.1.2 Recovery Scenarios (V, U, W, L)
  • 7.2 Partnership Sub-Segment Market Forecast, 2021-2031
    • 7.2.1 Introduction
    • 7.2.2 Recovery Scenarios (V, U, W, L)

8 Biobanking Market by Application (Pre COVID & Recovery Scenarios Included)

  • 8.1 Research: Growing Demand for Samples for Use in Commercial and Academic Research Studies
    • 8.1.1 Market Overview and Forecast, 2021 to 2031
    • 8.1.2 Recovery Scenarios (V, U, W, L)
  • 8.2 Therapeutics: Growing Number of Project Collaborations with Commercial Vendors Such as Pharmaceuticals, & Diagnostic Companies
    • 8.2.1 Market Overview and Forecast, 2021 to 2031
    • 8.2.2 Recovery Scenarios (V, U, W, L)

9 Biobanking Market by Sample Type (Pre COVID & Recovery Scenarios Included)

  • 9.1 Bio-fluids Sub-Segment Holds Majority of the Market Share
    • 9.1.1 Market Overview and Forecast, 2021 to 2031
    • 9.1.2 Recovery Scenarios (V, U, W, L)
  • 9.2 Human Tissue/Tumor Cells Sib-Segment to Grow on Account of Rising Oncology Studies
    • 9.2.1 Market Overview and Forecast, 2021 to 2031
    • 9.2.2 Recovery Scenarios (V, U, W, L)
  • 9.3 Stem Cells Sub-Segment to Grow Owing to Rising Focus on Rare Diseases & Regenerative Medicines
    • 9.3.1 Market Overview and Forecast, 2021 to 2031
    • 9.3.2 Recovery Scenarios (V, U, W, L)
  • 9.4 DNA/RNA Sub-Segment to Grow on Account of Rising Precision Medicine Market
    • 9.4.1 Market Overview and Forecast, 2021 to 2031
    • 9.4.2 Recovery Scenarios (V, U, W, L)
  • 9.5 Other Sample Types
    • 9.5.1 Market Overview and Forecast, 2021 to 2031
    • 9.5.2 Recovery Scenarios (V, U, W, L)

10 Biobanking Market by Ownership (Pre COVID & Recovery Scenarios Included)

  • 10.1 National/ Regional
    • 10.1.1 Market Overview and Forecast, 2021 to 2031
    • 10.1.2 Recovery Scenarios (V, U, W, L)
  • 10.2 Universities
    • 10.2.1 Market Overview and Forecast, 2021 to 2031
    • 10.2.2 Recovery Scenarios (V, U, W, L)
  • 10.3 Non-Profit
    • 10.3.1 Market Overview and Forecast, 2021 to 2031
    • 10.3.2 Recovery Scenarios (V, U, W, L)
  • 10.4 Private
    • 10.4.1 Market Overview and Forecast, 2021 to 2031
    • 10.4.2 Recovery Scenarios (V, U, W, L)

11 Regional and Leading National Biobanking Market Forecasts 2021-2031

  • 11.1 Global Biobanking Market by Region Forecast 2021-2031
  • 11.2 Recovery Scenarios (V, U, W, L)

12 North America Biobanking Market Forecasts, 2021-2031

  • 12.1 North America Biobanking Market by Country Forecast 2021-2031
  • 12.2 North America Biobanking Market Forecast by Biobank Type
  • 12.3 North America Biobanking Market Forecast by Application
  • 12.4 North America Biobanking Market Forecast by Sample Type
  • 12.5 North America Biobanking Market Forecast by Ownership
  • 12.6 U.S. Biobanking Market
    • 12.6.1 U.S. Biobanking Marketing Diversifying and Expanding
    • 12.6.2 U.S. Biobanking Market Forecast, 2021-2031
    • 12.6.3 Recovery Scenarios (V, U, W, L): U.S. Biobanking Market Forecast, 2021-2031
  • 12.7 Canada Biobanking Market
    • 12.7.1 Canada Biobanking Market Forecast, 2021-2031
    • 12.7.2 Recovery Scenarios (V, U, W, L): Canada Biobanking Market Forecast, 2021-2031

13 Europe Biobanking Market Forecasts, 2021-2031

  • 13.1 Europe Biobanking Market by Country Forecast 2021-2031
  • 13.2 Europe Biobanking Market Forecast by Biobank Type
  • 13.3 Europe Biobanking Market Forecast by Application
  • 13.4 Europe Biobanking Market Forecast by Sample Type
  • 13.5 Europe Biobanking Market Forecast by Ownership
  • 13.6 UK Biobanking Market
    • 13.6.1 Limited Presence of Biobanking Network
    • 13.6.2 UK Biobanking Market Forecast, 2021-2031
    • 13.6.3 Recovery Scenarios (V, U, W, L): UK Biobanking Market Forecast, 2021-2031
  • 13.7 France Biobanking Market
    • 13.7.1 Restriction on Private Stem Cell Banking Limit the Market
    • 13.7.2 France Biobanking Market Forecast, 2021-2031
    • 13.7.3 Recovery Scenarios (V, U, W, L): France Biobanking Market Forecast, 2021-2031
  • 13.8 Germany Biobanking Market
    • 13.8.1 Advanced Biobank Industry
    • 13.8.2 Germany Biobanking Market Forecast, 2021-2031
    • 13.8.3 Recovery Scenarios (V, U, W, L): Germany Biobanking Market Forecast, 2021-2031
  • 13.9 Italy Biobanking Market
    • 13.9.1 Restrictions on Stem Cell Banking Market
    • 13.9.2 Italy Biobanking Market Forecast, 2021-2031
    • 13.9.3 Recovery Scenarios (V, U, W, L): Italy Biobanking Market Forecast, 2021-2031
  • 13.10 Spain Biobanking Market
    • 13.10.1 Controversy Between Private and Public Umbilical Cord Blood Banks
    • 13.10.2 Spain Biobanking Market Forecast, 2021-2031
    • 13.10.3 Recovery Scenarios (V, U, W, L): Spain Biobanking Market Forecast, 2021-2031
  • 13.11 Russia Biobanking Market
    • 13.11.1 The Biobanking Movement in Russia is Expanding
    • 13.11.2 Russia Biobanking Market Forecast, 2021-2031
    • 13.11.3 Recovery Scenarios (V, U, W, L): Russia Biobanking Market Forecast, 2021-2031
  • 13.12 Denmark Biobanking Market
    • 13.12.1 Denmark Biobanking Market Forecast, 2021-2031
    • 13.12.2 Recovery Scenarios (V, U, W, L): Denmark Biobanking Market Forecast, 2021-2031
  • 13.13 Finland Biobanking Market
    • 13.13.1 Finland Biobanking Market Forecast, 2021-2031
    • 13.13.2 Recovery Scenarios (V, U, W, L): Finland Biobanking Market Forecast, 2021-2031
  • 13.14 Rest of Europe Biobanking Market
    • 13.14.1 Recovery Scenarios (V, U, W, L): Rest of Europe Biobanking Market Forecast, 2021-2031

14 Asia Pacific Biobanking Market Forecasts, 2021-2031

  • 14.1 Asia Pacific Biobanking Market by Country Forecast 2021-2031
  • 14.2 Asia Pacific Biobanking Market Forecast by Biobank Type
  • 14.3 Asia Pacific Biobanking Market Forecast by Application
  • 14.4 Asia Pacific Biobanking Market Forecast by Sample Type
  • 14.5 Asia Pacific Biobanking Market Forecast by Ownership
  • 14.6 Japan Biobanking Market
    • 14.6.1 Growing Government Investments to Fuel Market Growth
    • 14.6.2 Japan Biobanking Market Forecast, 2021-2031
    • 14.6.3 Recovery Scenarios (V, U, W, L): Japan Biobanking Market Forecast, 2021-2031
  • 14.7 China Biobanking Market
    • 14.7.1 Rapid Biobanking Market Growth Over the Past Years
    • 14.7.2 China Biobanking Market Forecast, 2021-2031
    • 14.7.3 Recovery Scenarios (V, U, W, L): China Biobanking Market Forecast, 2021-2031
  • 14.8 India Biobanking Market
    • 14.8.1 Anticipated to Witness the Highest Growth Between 2021 to 2031
    • 14.8.2 India Biobanking Market Forecast, 2021-2031
    • 14.8.3 Recovery Scenarios (V, U, W, L): India Biobanking Market Forecast, 2021-2031
  • 14.9 Rest of Asia Pacific Biobanking Market Forecast 2021-2031
    • 14.9.1 Rest of Asia Pacific Biobanking Market Forecast, 2021-2031
    • 14.9.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biobanking Market Forecast, 2021-2031

15 LAMEA Biobanking Market Forecasts, 2021-2031

  • 15.1 LAMEA Biobanking Market Forecast 2021-2031
    • 15.1.1 Recovery Scenarios (V, U, W, L): LAMEA Biobanking Market Forecast, 2021-2031
  • 15.2 LAMEA Biobanking Market Forecast by Biobank Type
  • 15.3 LAMEA Biobanking Market Forecast by Application
  • 15.4 LAMEA Biobanking Market Forecast by Sample Type
  • 15.5 LAMEA Biobanking Market Forecast by Ownership

16 Company Profiles

  • 16.1 Thermo Fisher Scientific Inc.
    • 16.1.1 Company Snapshot, 2020
    • 16.1.2 Company Overview
    • 16.1.3 Financial Analysis, 2015-2019
    • 16.1.4 Products
    • 16.1.5 Recent Developments, 2020
  • 16.2 Merck & Co.
    • 16.2.1 Company Snapshot, 2020
    • 16.2.2 Company Overview
    • 16.2.3 Financial Analysis, 2015-2019
    • 16.2.4 Products
  • 16.3 QIAGEN
    • 16.3.1 Company Snapshot, 2020
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis, 2015-2019
    • 16.3.4 Products
  • 16.4 Danaher
    • 16.4.1 Company Snapshot, 2020
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis, 2015-2019
  • 16.5 STEMCELL Technologies Inc.
    • 16.5.1 Company Snapshot, 2020
    • 16.5.2 Company Overview
    • 16.5.3 Recent Developments, 2018
  • 16.6 BioLifeSolutions Inc.
    • 16.6.1 Company Snapshot, 2020
    • 16.6.2 Company Overview
    • 16.6.3 Financial Analysis, 2015-2019
  • 16.7 BioCision
    • 16.7.1 Company Snapshot, 2020
    • 16.7.2 Company Overview
    • 16.7.3 Products
  • 16.8 VWR International, LLC.
    • 16.8.1 Company Snapshot, 2020
    • 16.8.2 Company Overview
    • 16.8.3 Products
    • 16.8.4 Recent Developments, 2018
  • 16.9 Hamilton Company
    • 16.9.1 Company Snapshot, 2020
    • 16.9.2 Company Overview
    • 16.9.3 Products
    • 16.9.4 Recent Developments, 2016
  • 16.10 Becton, Dickinson and Company (BD)
    • 16.10.1 Company Snapshot, 2020
    • 16.10.2 Company Overview
    • 16.10.3 Financial Analysis, 2015-2019

17 Conclusion

  • 17.1 Biobanks Are Important for Developing Personalized Medicines
  • 17.2 Biobanks Have an Impact on Biotech & Medical Innovation
  • 17.3 Increasing Demand for Biobanked Samples - Increasing Revenue
  • 17.4 Improving Biobanking Infrastructure - Growth Driver and a Need for Strategic Planning for Sustainability
  • 17.5 Marked Challenges, but Opportunities for Expansion
  • 17.6 Recommendations

List of Tables

  • Table 1 Prominent Population-Based Biobanks
  • Table 2 Prominent Disease-Based Biobanks
  • Table 3 Guidelines and Recommendations for Biobanks
  • Table 4 Laws and Other Regulations for Biobank-Based Research by Country/ Organization
  • Table 5 Pharmaceutical and Biotechnology Companies with In-House Biobanks
  • Table 6 Global Biobanking Market Snapshot, 2020 & 2031 (US$ billion, CAGR %)
  • Table 7 NORTH AMERICAN BIOBANKS
  • Table 8 UNITED STATES BIOBANKS
  • Table 9 EUROPEAN BIOBANKS
  • Table 10 ASIAN BIOBANKS
  • Table 11 AUSTRALIAN BIOBANKS
  • Table 12 MIDDLE EASTERN BIOBANKS
  • Table 13 Prominent Players in the Biobanking Industry for Research
  • Table 14 Prominent Companies Providing Automated Liquid Handling Technology
  • Table 15 Prominent Companies Providing Ultra-Low Temperature Freezers (-80°C)
  • Table 16 Mechanical Freezing vs. Liquid Nitrogen: Comparison of Advantages and Disadvantages
  • Table 17 Prominent Companies Providing Cryogenic Storage Solutions
  • Table 18 Prominent Providers of Automated Biobanking Systems
  • Table 19 Major Vendors in the LIMS Market
  • Table 20 Prominent Vendors of Consumables for Biobanking
  • Table 21 Global Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 22 Global Biobanking Market Forecast for Standalone, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 23 Global Biobanking Market Forecast for Standalone, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 24 Global Biobanking Market Forecast for Standalone, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 25 Global Biobanking Market Forecast for Standalone, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 26 Global Biobanking Market Forecast for Standalone, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 27 Global Biobanking Market Forecast for Partnership, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 28 Global Biobanking Market Forecast for Partnership, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 29 Global Biobanking Market Forecast for Partnership, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 30 Global Biobanking Market Forecast for Partnership, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 31 Global Biobanking Market Forecast for Partnership, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 32 Global Biobanking Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 33 Global Biobanking Market Forecast for Research, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 34 Global Biobanking Market Forecast for Research, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 35 Global Biobanking Market Forecast for Research, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 36 Global Biobanking Market Forecast for Research, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 37 Global Biobanking Market Forecast for Research, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 38 Global Biobanking Market Forecast for Therapeutics, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 39 Global Biobanking Market Forecast for Therapeutics, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 40 Global Biobanking Market Forecast for Therapeutics, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 41 Global Biobanking Market Forecast for Therapeutics, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 42 Global Biobanking Market Forecast for Therapeutics, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 43 Global Biobanking Market Forecast by Sample, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 44 Global Biobanking Market Forecast for Bio-Fluids, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 45 Global Biobanking Market Forecast for Bio-Fluids, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 46 Global Biobanking Market Forecast for Bio-Fluids, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 47 Global Biobanking Market Forecast for Bio-Fluids, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 48 Global Biobanking Market Forecast for Bio-Fluids, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 49 Global Biobanking Market Forecast for Human Tissue/Tumor Cells, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 50 Global Biobanking Market Forecast for Human Tissue/Tumor Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 51 Global Biobanking Market Forecast for Human Tissue/Tumor Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 52 Global Biobanking Market Forecast for Human Tissue/Tumor Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 53 Global Biobanking Market Forecast for Human Tissue/Tumor Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 54 Global Biobanking Market Forecast for Stem Cells, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 55 Global Biobanking Market Forecast for Stem Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 56 Global Biobanking Market Forecast for Stem Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 57 Global Biobanking Market Forecast for Stem Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 58 Global Biobanking Market Forecast for Stem Cells, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 59 Global Biobanking Market Forecast for DNA/RNA, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 60 Global Biobanking Market Forecast for DNA/RNA, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 61 Global Biobanking Market Forecast for DNA/RNA, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 62 Global Biobanking Market Forecast for DNA/RNA, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 63 Global Biobanking Market Forecast for DNA/RNA, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 64 Global Biobanking Market Forecast for Others, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 65 Global Biobanking Market Forecast for Others, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 66 Global Biobanking Market Forecast for Others, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 67 Global Biobanking Market Forecast for Others, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 68 Global Biobanking Market Forecast for Others, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 69 Global Biobanking Market Forecast by Ownership, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 70 Global Biobanking Market Forecast for National/Regional Agencies, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 71 Global Biobanking Market Forecast for National/Regional Agencies, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 72 Global Biobanking Market Forecast for National/Regional Agencies, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 73 Global Biobanking Market Forecast for National/Regional Agencies, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 74 Global Biobanking Market Forecast for National/Regional Agencies, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 75 Global Biobanking Market Forecast for Universities, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 76 Global Biobanking Market Forecast for Universities, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 77 Global Biobanking Market Forecast for Universities, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 78 Global Biobanking Market Forecast for Universities, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 79 Global Biobanking Market Forecast for Universities, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 80 Global Biobanking Market Forecast for Non-Profit, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 81 Global Biobanking Market Forecast for Non-Profit, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 82 Global Biobanking Market Forecast for Non-Profit, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 83 Global Biobanking Market Forecast for Non-Profit, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 84 Global Biobanking Market Forecast for Non-Profit, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 85 Global Biobanking Market Forecast for Private, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 86 Global Biobanking Market Forecast for Private, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 87 Global Biobanking Market Forecast for Private, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 88 Global Biobanking Market Forecast for Private, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 89 Global Biobanking Market Forecast for Private, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 90 Global Biobanking Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 91 Global Biobanking Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 92 Global Biobanking Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 93 Global Biobanking Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 94 Global Biobanking Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 95 North America Biobanking Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 96 North America Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 97 North America Biobanking Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 98 North America Biobanking Market Forecast by Sample, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 99 North America Biobanking Market Forecast by Ownership, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 100 U.S. Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 101 U.S. Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 102 U.S. Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 103 U.S. Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 104 U.S. Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 105 Canada Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 106 Canada Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 107 Canada Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 108 Canada Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 109 Canada Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 110 Europe Biobanking Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 111 Europe Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 112 Europe Biobanking Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 113 Europe Biobanking Market Forecast by Sample, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 114 Europe Biobanking Market Forecast by Ownership, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 115 UK Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 116 UK Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 117 UK Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 118 UK Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 119 UK Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 120 France Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 121 France Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 122 France Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 123 France Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 124 France Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 125 Germany Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 126 Germany Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 127 Germany Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 128 Germany Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 129 Germany Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 130 Italy Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 131 Italy Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 132 Italy Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 133 Italy Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 134 Italy Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 135 Spain Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 136 Spain Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 137 Spain Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 138 Spain Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 139 Spain Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 140 Russia Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 141 Russia Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 142 Russia Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 143 Russia Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 144 Russia Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 145 Denmark Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 146 Denmark Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 147 Denmark Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 148 Denmark Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 149 Denmark Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 150 Finland Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 151 Finland Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 152 Finland Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 153 Finland Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 154 Finland Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 155 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 156 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 157 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 158 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 159 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 160 Asia Pacific Biobanking Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 161 Asia Pacific Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 162 Asia Pacific Biobanking Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 163 Asia Pacific Biobanking Market Forecast by Sample, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 164 Asia Pacific Biobanking Market Forecast by Ownership, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 165 Japan Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 166 Japan Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 167 Japan Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 168 Japan Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 169 Japan Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 170 China Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 171 China Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 172 China Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 173 China Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 174 China Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 175 India Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 176 India Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 177 India Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 178 India Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 179 India Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 180 Rest of APAC Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 181 Rest of APAC Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 182 Rest of APAC Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 183 Rest of APAC Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 184 Rest of APAC Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 185 LAMEA Biobanking Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%)
  • Table 186 LAMEA Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 187 LAMEA Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 188 LAMEA Biobanking Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 189 LAMEA Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 190 LAMEA Biobanking Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 191 LAMEA Biobanking Market Forecast by Sample, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 192 LAMEA Biobanking Market Forecast by Ownership, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 193 Thermo Fisher Scientific Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 194 Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 195 Merck & Co.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 196 Merck & Co.: Product Portfolio
  • Table 197 QIAGEN: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 198 QIAGEN: Product Portfolio
  • Table 199 Danaher: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 200 STEMCELL Technologies Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 201 BioLifeSolutions Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 202 BioCision: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 203 BioCision: Product Portfolio
  • Table 204 VWR International, LLC.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 205 VWR International, LLC.: Product Portfolio
  • Table 206 Hamilton Company: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 207 Hamilton Company: Product Portfolio
  • Table 208 Becton, Dickinson and Company (BD): Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)

List of Figures

  • Figure 1 Processes Involved in Biobanking
  • Figure 2 The Classification of Biobanks
  • Figure 3 Global Biobanking Market: Market Trends
  • Figure 4 Porter's Analysis
  • Figure 5 Global Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ million, AGR %)
  • Figure 6 Global Biobanking Market Share Forecast by Biobank Type, 2021, 2026, 2031 (%)
  • Figure 7 Global Biobanking Market for Standalone Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 8 Global Biobanking Market for Standalone Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 9 Global Biobanking Market for Standalone Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 10 Global Biobanking Market for Standalone Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 11 Global Biobanking Market for Standalone Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 12 Global Biobanking Market for Partnership Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 13 Global Biobanking Market for Partnership Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 14 Global Biobanking Market for Partnership Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 15 Global Biobanking Market for Partnership Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 16 Global Biobanking Market for Partnership Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 17 Global Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ million, AGR %)
  • Figure 18 Global Biobanking Market Share Forecast by Biobank Type, 2021, 2026, 2031 (%)
  • Figure 19 Global Biobanking Market for Research Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 20 Global Biobanking Market for Research Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 21 Global Biobanking Market for Research Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 22 Global Biobanking Market for Research Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 23 Global Biobanking Market for Research Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 24 Global Biobanking Market for Therapeutics Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 25 Global Biobanking Market for Therapeutics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 26 Global Biobanking Market for Therapeutics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 27 Global Biobanking Market for Therapeutics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 28 Global Biobanking Market for Therapeutics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 29 Global Biobanking Market Forecast by Sample Type, 2021-2031 (US$ million, AGR %)
  • Figure 30 Global Biobanking Market Share Forecast by Sample Type, 2021, 2026, 2031 (%)
  • Figure 31 Global Biobanking Market for Bio-fluids Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 32 Global Biobanking Market for Bio-fluids Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 33 Global Biobanking Market for Bio-fluids Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 34 Global Biobanking Market for Bio-fluids Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 35 Global Biobanking Market for Bio-fluids Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 36 Global Biobanking Market for Human Tissue/Tumor Cells Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 37 Global Biobanking Market for Human Tissue/Tumor Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 38 Global Biobanking Market for Human Tissue/Tumor Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 39 Global Biobanking Market for Human Tissue/Tumor Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 40 Global Biobanking Market for Human Tissue/Tumor Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 41 Global Biobanking Market for Stem Cells Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 42 Global Biobanking Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 43 Global Biobanking Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 44 Global Biobanking Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 45 Global Biobanking Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 46 Global Biobanking Market for DNA/RNA Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 47 Global Biobanking Market for DNA/RNA Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 48 Global Biobanking Market for DNA/RNA Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 49 Global Biobanking Market for DNA/RNA Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 50 Global Biobanking Market for DNA/RNA Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 51 Global Biobanking Market for Other Sample Types Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 52 Global Biobanking Market for Other Sample Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 53 Global Biobanking Market for Other Sample Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 54 Global Biobanking Market for Other Sample Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 55 Global Biobanking Market for Other Sample Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 56 Global Biobanking Market Forecast by Ownership, 2021-2031 (US$ million, AGR %)
  • Figure 57 Global Biobanking Market Share Forecast by Ownership, 2021, 2026, 2031 (%)
  • Figure 58 Global Biobanking Market for National/ Regional Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 59 Global Biobanking Market for National/ Regional Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 60 Global Biobanking Market for National/ Regional Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 61 Global Biobanking Market for National/ Regional Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 62 Global Biobanking Market for National/ Regional Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 63 Global Biobanking Market for Universities Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 64 Global Biobanking Market for Universities Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 65 Global Biobanking Market for Universities Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 66 Global Biobanking Market for Universities Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 67 Global Biobanking Market for Universities Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 68 Global Biobanking Market for Non-Profit Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 69 Global Biobanking Market for Non-Profit Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 70 Global Biobanking Market for Non-Profit Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 71 Global Biobanking Market for Non-Profit Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 72 Global Biobanking Market for Non-Profit Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 73 Global Biobanking Market for Private Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 74 Global Biobanking Market for Private Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 75 Global Biobanking Market for Private Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 76 Global Biobanking Market for Private Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 77 Global Biobanking Market for Private Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 78 Global Biobanking Market Forecast by Region 2021-2031 (US$ billion)
  • Figure 79 Global Biobanking Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 80 Global Biobanking Market Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 81 Global Biobanking Market Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 82 Global Biobanking Market Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 83 Global Biobanking Market Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 84 North America Biobanking Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 85 North America Biobanking Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 86 North America Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ billion, AGR%)
  • Figure 87 North America Biobanking Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 88 North America Biobanking Market Forecast by Sample Type, 2021-2031 (US$ billion, AGR%)
  • Figure 89 North America Biobanking Market Forecast by Ownership, 2021-2031 (US$ billion, AGR%)
  • Figure 90 U.S. Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 91 U.S. Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 92 U.S. Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 93 U.S. Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 94 U.S. Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 95 Canada Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 96 Canada Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 97 Canada Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 98 Canada Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 99 Canada Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 100 Europe Biobanking Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 101 Europe Biobanking Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 102 Europe Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ billion, AGR%)
  • Figure 103 Europe Biobanking Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 104 Europe Biobanking Market Forecast by Sample Type, 2021-2031 (US$ billion, AGR%)
  • Figure 105 Europe Biobanking Market Forecast by Ownership, 2021-2031 (US$ billion, AGR%)
  • Figure 106 UK Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 107 UK Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 108 UK Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 109 UK Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 110 UK Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 111 France Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 112 France Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 113 France Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 114 France Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 115 France Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 116 Germany Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 117 Germany Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 118 Germany Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 119 Germany Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 120 Germany Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 121 Italy Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 122 Italy Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 123 Italy Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 124 Italy Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 125 Italy Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 126 Spain Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 127 Spain Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 128 Spain Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 129 Spain Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 130 Spain Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 131 Russia Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 132 Russia Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 133 Russia Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 134 Russia Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 135 Russia Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 136 Denmark Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 137 Denmark Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 138 Denmark Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 139 Denmark Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 140 Denmark Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 141 Finland Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 142 Finland Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 143 Finland Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 144 Finland Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 145 Finland Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 146 Rest of Europe Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 147 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 148 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 149 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 150 Rest of Europe Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 151 Asia Pacific Biobanking Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 152 Asia Pacific Biobanking Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 153 Asia Pacific Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ billion, AGR%)
  • Figure 154 Asia Pacific Biobanking Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 155 Asia Pacific Biobanking Market Forecast by Sample Type, 2021-2031 (US$ billion, AGR%)
  • Figure 156 Asia Pacific Biobanking Market Forecast by Ownership, 2021-2031 (US$ billion, AGR%)
  • Figure 157 Japan Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 158 Japan Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 159 Japan Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 160 Japan Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 161 Japan Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 162 China Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 163 China Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 164 China Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 165 China Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 166 China Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 167 India Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 168 India Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 169 India Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 170 India Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 171 India Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 172 Rest of Asia Pacific Biobanking Market Forecast 2021-2031 (US$ million, AGR %)
  • Figure 173 Rest of Asia Pacific Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 174 Rest of Asia Pacific Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 175 Rest of Asia Pacific Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 176 Rest of Asia Pacific Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 177 LAMEA Biobanking Market Forecast, 2021-2031 (US$ billion)
  • Figure 178 LAMEA Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 179 LAMEA Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 180 LAMEA Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 181 LAMEA Biobanking Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 182 LAMEA Biobanking Market Forecast by Biobank Type, 2021-2031 (US$ billion, AGR%)
  • Figure 183 LAMEA Biobanking Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 184 LAMEA Biobanking Market Forecast by Sample Type, 2021-2031 (US$ billion, AGR%)
  • Figure 185 LAMEA Biobanking Market Forecast by Ownership, 2021-2031 (US$ billion, AGR%)
  • Figure 186 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 187 Merck & Co.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 188 QIAGEN: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 189 Danaher: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 190 BioLifeSolutions Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 191 Becton, Dickinson and Company (BD): Net Revenue, 2015-2019 (US$ Mn, AGR%)

Companies Profiled in the Report::

  • Becton, Dickinson, and Company (BD)
  • BioCision
  • BioLifeSolutions Inc.
  • Danaher
  • Hamilton Company
  • Merck & Co.
  • QIAGEN
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC

List of Other Companies:

  • American CryoStem
  • Asterand Bioscience
  • Aurora Biomed
  • Autoscribe Informatics
  • AuxoCell Laboratories
  • AXM Shenyang
  • BioCells
  • BIOVIA
  • Caladrius Biosciences
  • California Cryobank Stem Cell Services LLC
  • Cells4Life
  • Inbiomed
  • Indivumed
  • IntegenX
  • International Stem Cell Corporation
  • LifeGene
  • OriGene
  • Pacific BioStorage
  • Panasonic Biomedical
  • Parelsnoer
  • Pharma Cells
  • Pharmacells Group
  • Pharmagene
  • Pop-Gen National Cohort
  • Popgen
  • Precision Bioservices
  • ProMedDx
  • ProteoGenex
  • StarLIMS
  • Steelgate
  • Stellacure
  • StemCyte
  • Stemgent
  • StemLife
  • StemSave
  • ViaCord
  • VidaPlus

List of Organizations Mentioned in the Report:

  • American Association of Tissue Banks
  • Australasian Biospecimen Network (ABN)
  • Bavarian Red Cross (BRK)
  • Biobank Ireland Trust
  • Centro Nazionale per le Risorse Biologiche (CNRB)
  • Coriell Institute for Medical Research
  • European Association for Predictive, Preventative & Personalised Medicine (EPMA)
  • European Health Risk Monitoring (EHRM)
  • Food and Drug Administration (FDA)
  • Harvard University
  • INSERM
  • Instituto de Salud Carlos III
  • International Agency for Research on Cancer (IARC)
  • International Air Transport Association (IATA)
  • International Society for Biological and Environmental Repositories (ISBER)
  • National Cancer Institute (NCI)
  • National Genome Research Network (NGFN)
  • National Institutes of General Medical Sciences
  • Northeastern University
  • Office of Biorepositories and Biospecimen Research (OBBR)
  • Russian Society for Biobanking and Biopreservation (RSBB)
  • Sechenov First Moscow Medical University (SFMMU)
  • Singapore Biobank (SBB)
  • Singapore Tissue Network (STN)
  • Spanish National Biobank Network
  • The Organisation for Economic Co-operation and Development (OECD)
  • UK Biobank
  • University of Manchester
  • US Department of Transportation (DOT)
  • World Health Organization (WHO)